Literature DB >> 33210115

Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations.

Yuxin Liu1, W Glenn McCluggage2, Teresa M Darragh3, Wenxin Zheng4, Jennifer M Roberts5, Kay J Park6, Pei Hui7, Morgan Blakely8, Keith Sigel9, Michael M Gaisa10.   

Abstract

OBJECTIVES: The Lower Anogenital Squamous Terminology (LAST) recommendations classify human papillomavirus-associated squamous lesions into low- and high-grade squamous intraepithelial lesions (LSILs/HSILs). Our study aimed to assess interobserver agreement among 6 experienced pathologists in assigning 40 anal lesions previously diagnosed as anal intraepithelial neoplasia 2 (AIN 2) to either HSIL or non-HSIL categories.
METHODS: Agreement based on photomicrographs of H&E alone or H&E plus p16 immunohistochemistry was calculated using κ coefficients.
RESULTS: Agreement was fair based on H&E alone (κ = 0.42; 95% confidence interval [CI], 0.34-0.52). Adding p16 improved agreement to moderate (κ = 0.55; 95% CI, 0.54-0.62). On final diagnosis, 21 cases (53%) had unanimous diagnoses, and 19 (47%) were divided. When designating p16 results as positive or negative, agreement was excellent (κ = 0.92; 95% CI, 0.83-0.95). Among variables (staining location, extent, and intensity), staining of the basal/parabasal layers was a consistent feature in cases with consensus for positive results (20/20). Of the 67 H&E diagnoses with conflicting p16 results, participants modified 32 (48%), downgrading 23 HSILs and upgrading 9 non-HSILs.
CONCLUSIONS: Although p16 increased interobserver agreement, disagreement remained considerable regarding intermediate lesions. p16 expression, particularly if negative, can reduce unwarranted HSIL diagnoses and unnecessary treatment. © American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Anal intraepithelial neoplasia 2; Human papillomavirus; Interobserver agreement; p16 Immunohistochemistry

Year:  2021        PMID: 33210115      PMCID: PMC8130877          DOI: 10.1093/ajcp/aqaa188

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  32 in total

1.  The LAST guidelines in clinical practice: implementing recommendations for p16 use.

Authors:  Lani K Clinton; Kyle Miyazaki; Asia Ayabe; James Davis; Pamela Tauchi-Nishi; David Shimizu
Journal:  Am J Clin Pathol       Date:  2015-12       Impact factor: 2.493

2.  Papillary Immature Metaplasia of the Anal Canal: A Low-grade Lesion That Can Mimic a High-grade Lesion.

Authors:  Jennifer M Roberts; Alyssa M Cornall; Deborah Ekman; Carmella Law; I Mary Poynten; Fengyi Jin; Richard J Hillman; David J Templeton; Sepehr N Tabrizi; Suzanne M Garland; Julia K Thurloe; Andrew E Grulich; Annabelle Farnsworth
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

Review 3.  Human papillomaviruses and cervical neoplasia: a model for carcinogenesis.

Authors:  M H Stoler
Journal:  Int J Gynecol Pathol       Date:  2000-01       Impact factor: 2.762

4.  Diagnosing Anal Squamous Intraepithelial Lesions With and Without p16: An Interobserver Variability Study.

Authors:  Uma Krishnamurti; Mohammad Mohammad; Ashley Monsrud; Mario Mosunjac; Gabriela Oprea; Krisztina Hanley; Talaat Tadros; Lisa Flowers; Marina Mosunjac
Journal:  J Low Genit Tract Dis       Date:  2020-01       Impact factor: 1.925

5.  The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.

Authors:  Philip E Castle; Mark H Stoler; Diane Solomon; Mark Schiffman
Journal:  Am J Clin Pathol       Date:  2007-05       Impact factor: 2.493

Review 6.  Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.

Authors:  Kate Cuschieri; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

7.  Electrocautery ablation of anal high-grade squamous intraepithelial lesions: Effectiveness and key factors associated with outcomes.

Authors:  Michael M Gaisa; Yuxin Liu; Ashish A Deshmukh; Kimberly L Stone; Keith M Sigel
Journal:  Cancer       Date:  2020-01-24       Impact factor: 6.860

8.  p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.

Authors:  Amaia Sagasta; Paola Castillo; Adela Saco; Aureli Torné; Roser Esteve; Lorena Marimon; Jaume Ordi; Marta Del Pino
Journal:  Mod Pathol       Date:  2015-11-06       Impact factor: 7.842

9.  Differences in the Immune Microenvironment of Anal Cancer Precursors by HIV Status and Association With Ablation Outcomes.

Authors:  Yuxin Liu; Michael M Gaisa; Xiaofei Wang; Talia H Swartz; Yotam Arens; Karen A Dresser; Carlie Sigel; Keith Sigel
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

10.  Cervical preneoplasia biomarkers: a conundrum for the community based gynecologic surgical pathologist.

Authors:  Louis-Jacques van Bogaert
Journal:  J Gynecol Oncol       Date:  2014-01-08       Impact factor: 4.401

View more
  1 in total

1.  Characterisation of anal intraepithelial neoplasia and anal cancer in HIV-positive men by immunohistochemical markers p16, Ki-67, HPV-E4 and DNA methylation markers.

Authors:  Ramon P van der Zee; Chris J L M Meijer; Tamzin Cuming; Alexander Kreuter; Miekel M van de Sandt; Wim G V Quint; Henry J C de Vries; Jan M Prins; Renske D M Steenbergen
Journal:  Int J Cancer       Date:  2021-08-04       Impact factor: 7.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.